Proceedings of the National Academy of Sciences, Volume 122, Issue 44, November 2025. Significanceβ-amyloid (Aβ)-degrading enzymes (ADEs) promote Aβ-clearance and counteract amyloidosis. Insufficient cerebral Aβ clearance has been demonstrated as an early and central pathophysiological alteration within the AD biological continuum. The …

Read original article